Physician profile
Lisa B Webb
NPI 1063458800
$16,193.90
in general payments reported to CMS, 2019-2025
58 companies · $2,722 in 2025
The $2,722 reported for 2025 was more than what 78% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,995 · 2020: $1,375 · 2021: $2,813 · 2022: $2,388 · 2023: $2,010 · 2024: $2,890 · 2025: $2,722.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,618 · Education: $4.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,617.79 |
| Education | $4.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,134.07 | 2021-2025 | Qulipta, Botox |
| Ucb, INC. | $1,509.43 | 2019-2025 | Rystiggo, Briviact, Nayzilam |
| Novartis Pharmaceuticals Corporation | $1,333.18 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $884.60 | 2019-2025 | Ajovy, Austedo Xr, Austedo Xr |
| Sk Life Science, INC. | $764.32 | 2020-2025 | |
| Amneal Pharmaceuticals LLC | $724.79 | 2019-2025 | Rytary, Lyvispah, Crexont |
| Acadia Pharmaceuticals INC | $674.85 | 2019-2025 | Nuplazid |
| Biogen, INC. | $670.10 | 2019-2025 | Vumerity, Tysabri, Skyclarys |
| Eisai INC. | $546.65 | 2020-2025 | |
| Alexion Pharmaceuticals, INC. | $496.85 | 2019-2025 | Ultomiris |
| Allergan, INC. | $475.72 | 2019-2022 | |
| Lilly USA, LLC | $460.84 | 2019-2025 | Kisunla, Amyvid |
| Pfizer INC. | $413.93 | 2023-2025 | |
| Argenx US, INC. | $390.92 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Emd Serono, INC. | $361.09 | 2019-2025 | Mavenclad |
Show all 58 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.